Related Experiment Video

Updated: Feb 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Clinical Trial Design in Juvenile Idiopathic Arthritis

Stephen J Balevic1, Mara L Becker2, Michael Cohen-Wolkowiez3

  • 1Division of Pediatric Rheumatology, Duke University Medical Center, 2301 Erwin Road, CHC, T-Level, Durham, NC, 27710, USA. stephen.balevic@duke.edu.

Paediatric Drugs
|June 15, 2017
PubMed

Insights

Pediatric clinical trials face unique challenges, but advances in rheumatology and trial design are improving outcomes. New approaches balance cost-effective treatments with safety for children, especially with biosimilar drugs.

Area of Science:

  • Pediatric rheumatology
  • Clinical trial design
  • Pharmacology

Background:

  • Pediatric clinical trials are essential for evidence-based practice but present unique challenges.
  • Developmental changes in children require specific considerations in trial design.
  • Legislative requirements and advances in pediatric rheumatology necessitate innovative trial approaches.

Purpose of the Study:

  • To review advances and challenges in pediatric clinical trials, particularly in rheumatology.
  • To discuss the integration of new therapeutic agents, including biosimilars, in pediatric populations.
  • To explore future directions for juvenile idiopathic arthritis (JIA) clinical trials.

Main Methods:

  • Review of current methodologies in pediatric clinical trial design.
  • Discussion of novel approaches including research networks and stakeholder involvement.
  • Exploration of precision medicine and clinical trial simulations.

Main Results:

  • New strategies enhance the feasibility and efficiency of pediatric clinical trials.
  • The use of biosimilar drugs presents opportunities and challenges in pediatric therapeutics.
  • Precision medicine offers a promising future for JIA trial classification and treatment.

Conclusions:

  • Advances in pediatric rheumatology are driving innovative clinical trial designs.
  • Balancing therapeutic innovation, cost-effectiveness, and safety is crucial for pediatric drug development.
  • Future JIA trials will likely leverage precision medicine and advanced methodologies for more generalizable results.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.2K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.3K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.3K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
338
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402